684 related articles for article (PubMed ID: 30075545)
21. The diagnostic role of dual-phase (18)F-FDG PET/CT in the characterization of solitary pulmonary nodules.
Demir Y; Polack BD; Karaman C; Ozdoğan O; Sürücü E; Ayhan S; Akkoçlu A; Ozdemir N
Nucl Med Commun; 2014 Mar; 35(3):260-7. PubMed ID: 24468852
[TBL] [Abstract][Full Text] [Related]
22. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y
BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287
[TBL] [Abstract][Full Text] [Related]
23. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
24. The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
Spadafora M; Evangelista L; Fiordoro S; Porcaro F; Sicignano M; Mansi L
Curr Radiopharm; 2020; 13(3):243-248. PubMed ID: 32186274
[TBL] [Abstract][Full Text] [Related]
25. Comparison of quantitatively analyzed dynamic area-detector CT using various mathematic methods with FDG PET/CT in management of solitary pulmonary nodules.
Ohno Y; Nishio M; Koyama H; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K
AJR Am J Roentgenol; 2013 Jun; 200(6):W593-602. PubMed ID: 23701089
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of dual-time
Pahk K; Chung JH; Kim S; Lee SH
Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of
Zhang Y; Han J; Li J; Cao J; Zhou Y; Deng S; Zhang B; Yang Y
J Cancer Res Clin Oncol; 2024 May; 150(5):265. PubMed ID: 38769201
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.
Dabrowska M; Krenke R; Korczynski P; Maskey-Warzechowska M; Zukowska M; Kunikowska J; Orłowski T; Chazan R
Medicine (Baltimore); 2015 Apr; 94(15):e666. PubMed ID: 25881842
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the diagnostic efficacy of
Niyonkuru A; Chen X; Bakari KH; Wimalarathne DN; Bouhari A; Arnous MMR; Lan X
Cancer Med; 2020 Feb; 9(3):931-942. PubMed ID: 31837121
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and
Jreige M; Dunet V; Letovanec I; Prior JO; Meuli RA; Beigelman-Aubry C; Schaefer N
J Nucl Med; 2020 Jan; 61(1):26-32. PubMed ID: 31227574
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis value of
Ye S; Meng S; Bian S; Zhao C; Yang J; Lei W
BMC Med Imaging; 2023 Feb; 23(1):28. PubMed ID: 36747135
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of CT and
Li H; Li L; Liu Y; Deng Y; Zhu Y; Huang L; Long T; Zeng L; Shu Y; Peng D
BMC Cancer; 2024 Apr; 24(1):434. PubMed ID: 38589832
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules.
Dalli A; Selimoglu Sen H; Coskunsel M; Komek H; Abakay O; Sergi C; Cetin Tanrikulu A
J BUON; 2013; 18(4):935-41. PubMed ID: 24344020
[TBL] [Abstract][Full Text] [Related]
34. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
Kim IJ; Kim SJ; Kim YS; Lee TH; Jeong YJ
Neoplasma; 2009; 56(1):33-9. PubMed ID: 19152243
[TBL] [Abstract][Full Text] [Related]
35. A model of malignant risk prediction for solitary pulmonary nodules on
Yu M; Wang Z; Yang G; Cheng Y
Thorac Cancer; 2020 May; 11(5):1211-1215. PubMed ID: 32162769
[TBL] [Abstract][Full Text] [Related]
36. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region.
Reyes N; Onadeko OO; Luraschi-Monjagatta Mdel C; Knox KS; Rennels MA; Walsh TK; Ampel NM
Lung; 2014 Aug; 192(4):589-93. PubMed ID: 24801058
[TBL] [Abstract][Full Text] [Related]
38. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
Simsek FS; Comak A; Asik M; Kuslu D; Balci TA; Ulutas H; Koroglu R; Kekilli E; Akatli A; Elmali F; Yalcin NC; Akyol H
Niger J Clin Pract; 2020 Jun; 23(6):842-847. PubMed ID: 32525121
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of tumor shadow disappearance rate on integrated PET/CT evaluation of solitary pulmonary nodules with low glucose metabolism.
Lin KH; Lee RC; Liu RS; Chang CY
Nucl Med Commun; 2016 Apr; 37(4):356-62. PubMed ID: 26796032
[TBL] [Abstract][Full Text] [Related]
40. The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
Choi EK; Park HL; Yoo IR; Kim SJ; Kim YK
Eur Radiol; 2020 Jan; 30(1):442-451. PubMed ID: 31338654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]